STRO earnings: a negative outcome, -5.0%

On November 8, 2022, SUTRO BIOPHARMA, INC. reached its earnings. The result was a negative outcome, and the stock moved -5.0% in the window around the event. It had already run +33.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.